Which, and How Limited Number of Polymorphisms Should Be Selected per Disease, Risk Assessment, Health Profile or Biological System?
Masana, L., Madan, T., Visvikis, S., Sass, C., Baranova, H., Bonnet, J., Dembinska, A., Ehrlich, H., Gueyffier, F., Schmitz, G., Siest, G., Zannis, V.Volume:
41
Language:
english
Journal:
Clinical Chemistry and Laboratory Medicine
DOI:
10.1515/cclm.2003.084
Date:
January, 2003
File:
PDF, 75 KB
english, 2003